Back
Edge
StocktwitsEarnings
Official STOCKTWITS Representative
symbol logo$BHST Q2 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.17 up 29.17% YoY • Reported revenue of $8.84M up 3.78% YoY • BioHarvest Sciences Inc. expects the CDMO business to generate $4-$5 million in revenue, while consolidated EBITDA losses are expected to be in the range of $3 million to $5 million.

Price since post

Full Details

Advertisement|Remove ads.